Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TELA Bio, Inc.TELA · Entity 7381 | Director | May 28, 2025 | May 30, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TELA Bio, Inc.
Report date May 28, 2025 · Filed May 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,470 |
Reported balance
After 2025-05-28 transaction · row 1
1 source rowRow 1 · 2025-05-28 · Grant · Acquired 7,950 · Balance 18,470 F1: These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.39 · Expires 2035-05-28 | Direct | 11,700 |
Reported balance
After 2025-05-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-28 · Grant · Acquired 11,700 · Balance 11,700 F2: The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
F2: The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2025 Filed May 30, 2025 16:18 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 11,700 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001062993-25-010577 · form4.xml · derivative · entry 2 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,700 Underlying: Common Stock · 11,700 shares Expires 2035-05-28 F2 · derivative.exercise_date: The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| May 28, 2025 Filed May 30, 2025 16:18 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 7,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010577 · form4.xml · nonDerivative · entry 1 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,470 F1 · shares: These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 17:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 6,200 | $0.00 Strike: $5.71 | $0.00 |
DisclosureSEC source: 0001062993-24-012092 · form4.xml · derivative · entry 2 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,200 Underlying: Common Stock · 6,200 shares Expires 2034-06-04 F2 · derivative.exercise_date: The option vests on the earlier of (a) June 4, 2025, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 17:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 4,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-012092 · form4.xml · nonDerivative · entry 1 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,520 F1 · shares: These restricted stock units vest on the earlier of (a) June 4, 2025, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 16:37 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 5,360 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001062993-23-012777 · form4.xml · derivative · entry 2 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,360 Underlying: Common Stock · 5,360 shares Expires 2033-06-01 F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 16:37 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 3,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012777 · form4.xml · nonDerivative · entry 1 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,270 F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 16:06 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 5,360 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0001062993-22-014130 · form4.xml · derivative · entry 2 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,360 Underlying: Common Stock · 5,360 shares Expires 2032-06-01 F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2023, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Peron's continued service through the applicable vesting date. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 16:06 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 3,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-014130 · form4.xml · nonDerivative · entry 1 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,135 F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2023, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Peron's continued service through the applicable vesting date. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 16:53 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 10,825 | $0.00 Strike: $13.16 | $0.00 |
DisclosureSEC source: 0001192482-21-000489 · edgar.xml · derivative · entry 1 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,825 Underlying: Common Stock · 10,825 shares Expires 2031-06-02 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 2, 2022, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 16:36 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 8,806 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000447 · edgar.xml · derivative · entry 1 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,806 Underlying: Common Stock · 8,806 shares Expires 2030-06-04 F1 · derivative.exercise_date: The option vests on the earlier of (a) the first anniversary of June 4, 2020, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan), subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 20:44 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $8.42 | $0.00 |
DisclosureSEC source: 0001192482-20-000303 · edgar.xml · derivative · entry 1 EVANS DOUGLAS G · CIK 0001225164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2030-04-20 F1 · derivative.exercise_date: The option vests in 36 equal monthly installments on each monthly anniversary of April 20, 2020, subject to the Reporting Person's continuous service with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.